Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 92 entries
Sorted by: Best Match Show Resources per page
Seasonal change in the wetting characteristics of the cuticle of the Collembola .

Zoomorphology

Gundersen H, Thaulow C, Leinaas HP.
PMID: 25995534
Zoomorphology. 2015;134(2):211-218. doi: 10.1007/s00435-015-0254-y. Epub 2015 Feb 06.

The littoral Collembola

Cite
Gundersen H, Thaulow C, Leinaas HP. Seasonal change in the wetting characteristics of the cuticle of the Collembola . Zoomorphology. 2015;134(2):211-218doi: 10.1007/s00435-015-0254-y.
Gundersen, H., Thaulow, C., & Leinaas, H. P. (2015). Seasonal change in the wetting characteristics of the cuticle of the Collembola . Zoomorphology, 134(2), 211-218. https://doi.org/10.1007/s00435-015-0254-y
Gundersen, Håkon, et al. "Seasonal change in the wetting characteristics of the cuticle of the Collembola ." Zoomorphology vol. 134,2 (2015): 211-218. doi: https://doi.org/10.1007/s00435-015-0254-y
Gundersen H, Thaulow C, Leinaas HP. Seasonal change in the wetting characteristics of the cuticle of the Collembola . Zoomorphology. 2015;134(2):211-218. doi: 10.1007/s00435-015-0254-y. Epub 2015 Feb 06. PMID: 25995534; PMCID: PMC4430596.
Copy Download .nbib Format: NLM
Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms.

BioPsychoSocial medicine

Sulheim D, Hurum H, Helland IB, Thaulow E, Wyller VB.
PMID: 22436201
Biopsychosoc Med. 2012 Mar 21;6:10. doi: 10.1186/1751-0759-6-10.

BACKGROUND: The pathophysiology of chronic fatigue syndrome (CFS) in adolescents is unknown, and the clinical course and prognosis is still questioned. Recent research indicates that abnormalities of autonomic cardiovascular control may play an important role. The aim of this...

Cite
Sulheim D, Hurum H, Helland IB, et al. Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. Biopsychosoc Med. 2012;6:10doi: 10.1186/1751-0759-6-10.
Sulheim, D., Hurum, H., Helland, I. B., Thaulow, E., & Wyller, V. B. (2012). Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. BioPsychoSocial medicine, 610. https://doi.org/10.1186/1751-0759-6-10
Sulheim, Dag, et al. "Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms." BioPsychoSocial medicine vol. 6 (2012): 10. doi: https://doi.org/10.1186/1751-0759-6-10
Sulheim D, Hurum H, Helland IB, Thaulow E, Wyller VB. Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. Biopsychosoc Med. 2012 Mar 21;6:10. doi: 10.1186/1751-0759-6-10. PMID: 22436201; PMCID: PMC3337799.
Copy Download .nbib Format: NLM
Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms.

BioPsychoSocial medicine

Sulheim D, Hurum H, Helland IB, Thaulow E, Wyller VB.
PMID: 22436201
Biopsychosoc Med. 2012 Mar 21;6:10. doi: 10.1186/1751-0759-6-10.

BACKGROUND: The pathophysiology of chronic fatigue syndrome (CFS) in adolescents is unknown, and the clinical course and prognosis is still questioned. Recent research indicates that abnormalities of autonomic cardiovascular control may play an important role. The aim of this...

Cite
Sulheim D, Hurum H, Helland IB, et al. Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. Biopsychosoc Med. 2012;6:10doi: 10.1186/1751-0759-6-10.
Sulheim, D., Hurum, H., Helland, I. B., Thaulow, E., & Wyller, V. B. (2012). Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. BioPsychoSocial medicine, 610. https://doi.org/10.1186/1751-0759-6-10
Sulheim, Dag, et al. "Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms." BioPsychoSocial medicine vol. 6 (2012): 10. doi: https://doi.org/10.1186/1751-0759-6-10
Sulheim D, Hurum H, Helland IB, Thaulow E, Wyller VB. Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. Biopsychosoc Med. 2012 Mar 21;6:10. doi: 10.1186/1751-0759-6-10. PMID: 22436201; PMCID: PMC3337799.
Copy Download .nbib Format: NLM
Staining immunoblots for total protein using ponceau s.

CSH protocols

Harlow E, Lane D.
PMID: 22485666
CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4269.

No abstract available.

Cite
Harlow E, Lane D. Staining immunoblots for total protein using ponceau s. CSH Protoc. 2006;2006(1)doi: 10.1101/pdb.prot4269.
Harlow, E., & Lane, D. (2006). Staining immunoblots for total protein using ponceau s. CSH protocols, 2006(1), . https://doi.org/10.1101/pdb.prot4269
Harlow, Ed, and Lane, David. "Staining immunoblots for total protein using ponceau s." CSH protocols vol. 2006,1 (2006). doi: https://doi.org/10.1101/pdb.prot4269
Harlow E, Lane D. Staining immunoblots for total protein using ponceau s. CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4269. PMID: 22485666.
Copy Download .nbib Format: NLM
Preparing acetone powders.

CSH protocols

Harlow E, Lane D.
PMID: 22485681
CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4305.

No abstract available.

Cite
Harlow E, Lane D. Preparing acetone powders. CSH Protoc. 2006;2006(1)doi: 10.1101/pdb.prot4305.
Harlow, E., & Lane, D. (2006). Preparing acetone powders. CSH protocols, 2006(1), . https://doi.org/10.1101/pdb.prot4305
Harlow, Ed, and Lane, David. "Preparing acetone powders." CSH protocols vol. 2006,1 (2006). doi: https://doi.org/10.1101/pdb.prot4305
Harlow E, Lane D. Preparing acetone powders. CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4305. PMID: 22485681.
Copy Download .nbib Format: NLM
Binding antibodies to tissue sections.

CSH protocols

Harlow E, Lane D.
PMID: 22485707
CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4331.

No abstract available.

Cite
Harlow E, Lane D. Binding antibodies to tissue sections. CSH Protoc. 2006;2006(1)doi: 10.1101/pdb.prot4331.
Harlow, E., & Lane, D. (2006). Binding antibodies to tissue sections. CSH protocols, 2006(1), . https://doi.org/10.1101/pdb.prot4331
Harlow, Ed, and Lane, David. "Binding antibodies to tissue sections." CSH protocols vol. 2006,1 (2006). doi: https://doi.org/10.1101/pdb.prot4331
Harlow E, Lane D. Binding antibodies to tissue sections. CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4331. PMID: 22485707.
Copy Download .nbib Format: NLM
Counterstains.

CSH protocols

Harlow E, Lane D.
PMID: 22485714
CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4338.

No abstract available.

Cite
Harlow E, Lane D. Counterstains. CSH Protoc. 2006;2006(1)doi: 10.1101/pdb.prot4338.
Harlow, E., & Lane, D. (2006). Counterstains. CSH protocols, 2006(1), . https://doi.org/10.1101/pdb.prot4338
Harlow, Ed, and Lane, David. "Counterstains." CSH protocols vol. 2006,1 (2006). doi: https://doi.org/10.1101/pdb.prot4338
Harlow E, Lane D. Counterstains. CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4338. PMID: 22485714.
Copy Download .nbib Format: NLM
Fixing attached cells in paraformaldehyde.

CSH protocols

Harlow E, Lane D.
PMID: 22485842
CSH Protoc. 2006 Aug 01;2006(3). doi: 10.1101/pdb.prot4294.

No abstract available.

Cite
Harlow E, Lane D. Fixing attached cells in paraformaldehyde. CSH Protoc. 2006;2006(3)doi: 10.1101/pdb.prot4294.
Harlow, E., & Lane, D. (2006). Fixing attached cells in paraformaldehyde. CSH protocols, 2006(3), . https://doi.org/10.1101/pdb.prot4294
Harlow, Ed, and Lane, David. "Fixing attached cells in paraformaldehyde." CSH protocols vol. 2006,3 (2006). doi: https://doi.org/10.1101/pdb.prot4294
Harlow E, Lane D. Fixing attached cells in paraformaldehyde. CSH Protoc. 2006 Aug 01;2006(3). doi: 10.1101/pdb.prot4294. PMID: 22485842.
Copy Download .nbib Format: NLM
Immunoblotting: preparing cell lysates.

CSH protocols

Harlow E, Lane D.
PMID: 22485847
CSH Protoc. 2006 Aug 01;2006(3). doi: 10.1101/pdb.prot4299.

No abstract available.

Cite
Harlow E, Lane D. Immunoblotting: preparing cell lysates. CSH Protoc. 2006;2006(3)doi: 10.1101/pdb.prot4299.
Harlow, E., & Lane, D. (2006). Immunoblotting: preparing cell lysates. CSH protocols, 2006(3), . https://doi.org/10.1101/pdb.prot4299
Harlow, Ed, and Lane, David. "Immunoblotting: preparing cell lysates." CSH protocols vol. 2006,3 (2006). doi: https://doi.org/10.1101/pdb.prot4299
Harlow E, Lane D. Immunoblotting: preparing cell lysates. CSH Protoc. 2006 Aug 01;2006(3). doi: 10.1101/pdb.prot4299. PMID: 22485847.
Copy Download .nbib Format: NLM
Fixing Caenorhabditis elegans in Paraformaldehyde.

CSH protocols

Harlow E, Lane D.
PMID: 22485904
CSH Protoc. 2006 Sep 01;2006(4). doi: 10.1101/pdb.prot4522.

INTRODUCTIONAnother common method for fixing worms is to use paraformaldehyde. This method provides a gentler fixation than the Bouin's method, but often requires the use of collagenase. This method is particularly good for examining adult worms.

Cite
Harlow E, Lane D. Fixing Caenorhabditis elegans in Paraformaldehyde. CSH Protoc. 2006;2006(4)doi: 10.1101/pdb.prot4522.
Harlow, E., & Lane, D. (2006). Fixing Caenorhabditis elegans in Paraformaldehyde. CSH protocols, 2006(4), . https://doi.org/10.1101/pdb.prot4522
Harlow, Ed, and Lane, David. "Fixing Caenorhabditis elegans in Paraformaldehyde." CSH protocols vol. 2006,4 (2006). doi: https://doi.org/10.1101/pdb.prot4522
Harlow E, Lane D. Fixing Caenorhabditis elegans in Paraformaldehyde. CSH Protoc. 2006 Sep 01;2006(4). doi: 10.1101/pdb.prot4522. PMID: 22485904.
Copy Download .nbib Format: NLM
Immunoprecipitation: denaturing lysis.

CSH protocols

Harlow E, Lane D.
PMID: 22485916
CSH Protoc. 2006 Sep 01;2006(4). doi: 10.1101/pdb.prot4534.

INTRODUCTIONFor many sources of antigens, one useful method of lysis is to treat cells with harsh, denaturing solutions to release most of the protein antigens, as described here. The lysates are then diluted to reduce the denaturing conditions to...

Cite
Harlow E, Lane D. Immunoprecipitation: denaturing lysis. CSH Protoc. 2006;2006(4)doi: 10.1101/pdb.prot4534.
Harlow, E., & Lane, D. (2006). Immunoprecipitation: denaturing lysis. CSH protocols, 2006(4), . https://doi.org/10.1101/pdb.prot4534
Harlow, Ed, and Lane, David. "Immunoprecipitation: denaturing lysis." CSH protocols vol. 2006,4 (2006). doi: https://doi.org/10.1101/pdb.prot4534
Harlow E, Lane D. Immunoprecipitation: denaturing lysis. CSH Protoc. 2006 Sep 01;2006(4). doi: 10.1101/pdb.prot4534. PMID: 22485916.
Copy Download .nbib Format: NLM
Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).

Gene therapy

Adair JE, Androski L, Bayigga L, Bazira D, Brandon E, Dee L, Deeks S, Draz M, Dubé K, Dybul M, Gurkan U, Harlow E, Kityo C, Louella M, Malik P, Mathews V, McKemey A, Mugerwa H, Muyanja D, Olayiwola O, Orentas RJ, Popovski A, Sheehy J, Ssali F, Nsubuga MS, Tisdale JF, Verhoeyen E, Dropulić B.
PMID: 34584245
Gene Ther. 2021 Sep 29; doi: 10.1038/s41434-021-00293-3. Epub 2021 Sep 29.

No abstract available.

Cite
Adair JE, Androski L, Bayigga L, et al. Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI). Gene Ther. 2021;doi: 10.1038/s41434-021-00293-3.
Adair, J. E., Androski, L., Bayigga, L., Bazira, D., Brandon, E., Dee, L., Deeks, S., Draz, M., Dubé, K., Dybul, M., Gurkan, U., Harlow, E., Kityo, C., Louella, M., Malik, P., Mathews, V., McKemey, A., Mugerwa, H., Muyanja, D., Olayiwola, O., Orentas, R. J., Popovski, A., Sheehy, J., Ssali, F., Nsubuga, M. S., Tisdale, J. F., Verhoeyen, E., & Dropulić, B. (2021). Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI). Gene therapy, . https://doi.org/10.1038/s41434-021-00293-3
Adair, Jennifer E, et al. "Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)." Gene therapy vol. (2021). doi: https://doi.org/10.1038/s41434-021-00293-3
Adair JE, Androski L, Bayigga L, Bazira D, Brandon E, Dee L, Deeks S, Draz M, Dubé K, Dybul M, Gurkan U, Harlow E, Kityo C, Louella M, Malik P, Mathews V, McKemey A, Mugerwa H, Muyanja D, Olayiwola O, Orentas RJ, Popovski A, Sheehy J, Ssali F, Nsubuga MS, Tisdale JF, Verhoeyen E, Dropulić B. Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI). Gene Ther. 2021 Sep 29; doi: 10.1038/s41434-021-00293-3. Epub 2021 Sep 29. PMID: 34584245.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 92 entries